OSU’s New Nanoparticles Deliver Gene Therapies to the Exact Right Place to Fight Lung Diseases, Cancer
June 18, 2025
A story in The Corvallis Advocate covers a key breakthrough for treating respiratory diseases by developing a new drug delivery system that transports genetic therapies directly to the lungs, opening promising possibilities for patients with conditions like lung cancer and cystic fibrosis. The research was a collaboration among OSU, OHSU and the University of Helsinki.